A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Public ClinicalTrials.gov record NCT06100744. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-label, Randomized, Assessor-blinded, Efficacy, Safety, Tolerability, and Pharmacokinetics Study of Subcutaneous Risankizumab With an Adalimumab Reference Arm in Children With Active Juvenile Psoriatic Arthritis
Study identification
- NCT ID
- NCT06100744
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- Adalimumab Drug
- Risankizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 5 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2024
- Primary completion
- Aug 31, 2026
- Completion
- Sep 30, 2028
- Last update posted
- Feb 17, 2026
2024 – 2028
United States locations
- U.S. sites
- 9
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Children's Hospital /ID# 258776 | Little Rock | Arkansas | 72202 | Recruiting |
| Childrens National Medical Center /ID# 259284 | Washington D.C. | District of Columbia | 20010-2916 | Recruiting |
| Joe Dimaggio Children's Hospital Hollywood /ID# 260634 | Hollywood | Florida | 33021 | Recruiting |
| Indiana University Health Riley Hospital for Children /ID# 259067 | Indianapolis | Indiana | 46202 | Recruiting |
| M Health Fairview University of Minnesota Medical Center - West Bank /ID# 260111 | Minneapolis | Minnesota | 55454 | Recruiting |
| Boston Childrens Health Physicians /ID# 258061 | Valhalla | New York | 10595 | Recruiting |
| University of North Carolina - Children's Hospital /ID# 259286 | Chapel Hill | North Carolina | 27514 | Recruiting |
| MetroHealth Medical Center /ID# 262377 | Cleveland | Ohio | 44109 | Recruiting |
| Child Neurology Consultants of Austin /ID# 260562 | Austin | Texas | 78757-7571 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06100744, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 17, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06100744 live on ClinicalTrials.gov.